Head of LBA Bioanalysis

GSK•Upper Providence Township, PA

10d•Hybrid

About The Position

You will lead the Ligand Binding Assay (LBA) bioanalysis function in the Bioanalytical and Biomarker Platforms (BBP) department in GSK. You will be responsible for the development, validation, and execution of high‑quality bioanalytical assays, ensuring data integrity, regulatory compliance, and timely delivery to project teams for the entire GSK Biopharm portfolio across all therapeutical areas. You will set scientific direction and partner across drug development teams. Your role will combine technical leadership, people development and operational oversight. We value clear decision-making, practical problem solving, and a commitment to patient-centred science. You will have the chance to grow your career, shape bioanalytical strategy, and make an impact that helps get ahead of disease together.

Requirements

PhD in Biology, Biochemistry, or a related scientific discipline with 8 years of industry experience in ligand‑binding bioanalysis within pharma or biotech. M.S. with at least 15 years of industry experience will be considered as well.
Prior leadership experience managing scientists and/or technical teams and operational workflows in a regulated environment.
Experience with LBA methodologies and platforms such as ELISA, MSD and bioanalytical problem‑solving.
Proven ability to lead complex programs and influence cross‑functional teams. Experience in working with clinical pharmacology to align on PK assay strategy, balancing assay robustness, regulatory compliance, and phase appropriate scientific objectives.
Hands-on experience with data management systems and laboratory information management systems (LIMS).

Nice To Haves

Demonstrated experience managing CRO/vendor partnerships and ensuring data quality and compliance.
Experience in driving broader bioanalytical strategies, including PK, biomarkers, and immunogenicity endpoints.
Experience supporting oligonucleotides or complex modalities such as ADCs through early and late-stage clinical development.
Familiarity with regulatory submissions and responses related to bioanalysis (e.g., supporting clinical study reports and regulatory queries).
Experience driving laboratory transformation projects such as digitalisation, automation, or analytics-driven QC.

Responsibilities

Serve as the head of the LBA PK group, managing a team of 5-6 lab scientists. Oversee workload planning, resource allocation, and work with partners on prioritization across multiple programs.
Drive LBA PK bioanalytical strategy. Ensure assays are aligned with study phase, regulatory expectations, and scientific objectives.
Provide expert leadership in LBA PK assay development, validation, and sample analysis to support early stage clinical programs.
Provide technical support to transfer LBA PK assays to external CROs for late stage support. Help trouble shoot LBA PK assays outsourced to CROs.
Evaluate LBA PK assays of in-licensed assets. Re-develop/optimize if needed.
Partner with project teams to define bioanalytical plans, timelines, and deliverables. Represent LBA bioanalysis in project teams. Provide clear LBA PK assay related scientific input to inform development decisions and risk assessments.
Ensure compliance with GLP/GCP, internal SOPs, and data integrity standards. Support internal audits, inspections, and regulatory submissions as needed.
Lead, mentor, and develop a team of bioanalytical scientists and/or matrixed contributors. Set clear expectations, provide scientific coaching, and support career development.
Contribute to the long‑term bioanalysis and biomarker strategy within the organization.
Drive continuous improvement and innovation in LBA bioanalysis capabilities. Evaluate and introduce new assay platforms, technologies, and workflows. Identify and implement opportunities to improve efficiency and quality.